Meet Dorra Pharma, a leading pharmaceutical supply chain services provider, manufacturer of high-quality generic active pharmaceutical ingredients (APIs) and intermediates

Dorra Pharma announces its participation in the upcoming Pharmtech & Ingredients exhibition, which will be held from 19 to 22 November 2024. This event provides an excellent opportunity for Dorra to establish connections with Russian pharmaceutical companies, healthcare leaders and regulators to reaffirm its commitment to meeting the demand for safe, effective and reliable pharmaceutical solutions.

Commitment to efficient, transparent and reliable supply chain services

As a trusted partner in pharmaceutical supply chain management, Dorra delivers integrated and technology-based solutions designed to streamline complex processes for pharmaceutical companies. With a network spanning multiple regions and over 3,000 trusted and regulated suppliers in China, Dorra aims to ensure smooth supply chains and on-time delivery.

In line with the strict quality requirements of the global pharmaceutical industry, Dorra also supports suppliers in improving their quality management systems in line with regulations. This proactive approach ensures that products meet the regulatory expectations of international markets, including Russia.

Supplying high quality generics, active pharmaceutical ingredients and intermediates: quality and affordability in one bottle

Dorra also offers a broad portfolio of in-house developed generic APIs and intermediates. With over 20 years of experience in the pharmaceutical and chemical markets, in-house products are designed to meet the quality, regulatory and affordability requirements of both new and established pharmaceutical companies. By focusing on high manufacturing control standards and leveraging extensive R&D capabilities, the company ensures that products meet stringent international standards, making them relevant for Russia.

As demand for generic drugs continues to grow globally, Dorra provides Russian pharmaceutical companies with reliable, cost-effective options to meet patient needs. With strict quality control at every stage of production - from raw material supply to final APIs - Dorra ensures the quality and competitiveness of its products.

Personalized and ready-made solutions for Russian partners

Dorra’s business model goes beyond delivering high-quality products; it emphasizes a holistic approach to partnership. Given the unique needs of the Russian market, Dorra offers a full service cycle that includes raw material sourcing, quality assurance, and a dedicated team to ensure local regulatory compliance. This model helps pharmaceutical companies bring high-quality, affordable medicines to market quickly and efficiently.

In addition to its own APIs, Dorra can assist customers with product registration, regulatory compliance, and risk management processes.

Confidence in the future through innovation and sustainability

Dorra Pharma’s commitment to sustainability is central to its operations and supply chain management approach. From reducing emissions to optimizing transportation, the company continually invests in greener solutions that reduce its carbon footprint. By implementing sustainable practices, Dorra not only meets global environmental goals, but also meets the growing expectations of Russian stakeholders for environmentally responsible business.

The company aims to deepen cooperation with Russian partners, share expertise on its advanced supply chain and API solutions, and explore new ways to address the changing needs of the pharmaceutical industry. With a focus on quality, innovation, and partnership, Dorra is ready to help Russian companies overcome supply chain challenges and deliver high-quality, affordable products to the region.

Dorra is looking forward to connecting with new partners, sharing innovative solutions, and paving the way for a healthier, more connected world together. Join the company as we explore a future where quality, affordability, and innovation go hand in hand.